Market Power and Regulation in Pharmaceutical Markets

Publication: Working/Discussion PaperWU Working Paper

328 Downloads (Pure)

Abstract

We exploit the regulatory environment in the Austrian pharmaceutical market to study the effects of price regulation on market outcomes and consumer welfare. We evaluate all mergers of drug producers in the 2009-2017 period and find that the coexisting regulated and unregulated markets were unequally affected. While M&A have substantially increased prices without regulation, particularly for price-inelastic products, prices did not increase under regulation. Instead, variety increased in regulated markets. Therefore, regulation can successfully mitigate the effects of market power: whereas M&A decrease consumer welfare absent regulation, the additional product variety increases consumer welfare in the regulated market.
Original languageEnglish
PublisherWU Vienna University of Economics and Business
DOIs
Publication statusPublished - Jul 2023

Publication series

SeriesDepartment of Economics Working Paper Series
Number343

WU Working Paper Series

  • Department of Economics Working Paper Series

Keywords

  • pharmaceuticals
  • regulation
  • market power
  • consumer welfare
  • pharma mergers
  • product variety

Cite this